Medtronic Plc (MDT) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
Medtronic Plc  (NYSE: MDT)
 

Medtronic Plc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MDT Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 13.73 % 7.07 % 8.07 % 9.17 %
Q / Q Revenue Growth (Q2 MRQ) -0.53 % 1.17 % 1.81 % 4.22 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 9.77 % 5.73 % 7.04 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 3.24 % 1.89 % 3.51 % 2.08 %
Revenue 5 Year Average Growth 3.84 % 10.68 % 8.65 % 10.59 %


MDT's Growth Comparisons in I. Quarter 2026




Medtronic Plc improved it's Revenue by 13.73% year on year in the first quarter 2026, and outpaced the 7.07% growth in the Medical Equipment & Supplies industry, and 8.07% growth in the Healthcare sector. Despite modest Sales rises in the Healthcare sector and in the Medical Equipment & Supplies industry, Medtronic Plc reported above average market Sales growth.

Top-line fell by -0.53% from the fourth quarter. Average annual sales growth for Medtronic Plc is 3.84%, while S & P 500's average yearly sales increase is 10.59%, including only Businesses with the first quarter 2026 financial results.

MDT Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Total Reportable Segments
8.78 %
0.66 %
Cardiovascular
13.83 %
0.61 %
Cardiovascular Cardiac Rhythm Heart Failure
20.13 %
1.7 %
Cardiovascular Structural Heart Aortic
6.29 %
-2.82 %
Cardiovascular Coronary Peripheral Vascular
8.74 %
2.6 %
Neuroscience
4.07 %
-0.16 %
Neuroscience Cranial Spinal Technologies
4.8 %
0.85 %
Neuroscience Specialty Therapies
1.91 %
0.27 %
Neuroscience Neuromodulation
5.67 %
-3.27 %
Medical Surgical
4.87 %
0.09 %
Medical Surgical Surgical Endoscopy
3.63 %
-1.49 %
Medical Surgical Acute Care Monitoring
9.03 %
5.27 %
Diabetes
14.7 %
5.15 %
Other segment
0 %
-8.57 %
U S
6.04 %
-0.51 %
International
11.57 %
1.78 %
Reportable net sales
8.78 %
0.66 %
Reportable net sales U S
5.97 %
-0.42 %
Reportable net sales International
11.69 %
1.76 %
Cardiovascular U S
13.1 %
-0.19 %
Cardiovascular International
14.46 %
1.3 %
Neuroscience U S
1.18 %
-1.21 %
Neuroscience International
10.4 %
2.04 %
Medical Surgical U S
4.03 %
-1.48 %
Medical Surgical International
5.42 %
1.3 %
Diabetes U S
5.08 %
7.83 %
Diabetes International
19.91 %
3.98 %
Other U S
20 %
-18.18 %
Other International
-17.65 %
7.69 %
Ireland
28.57 %
2.86 %
Total other countries excluding Ireland
8.68 %
0.62 %
United States
6.04 %
-0.51 %
Rest of world
11.45 %
1.77 %
Total
8.74 %
0.62 %


Growth Rates of MDT's Income in the first quarter 2026


MDT Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) 22.08 % -22.54 % 27.58 % 29.95 %
Sequential Operating Income Change (Q2 MRQ) -5.77 % -56.34 % -17.34 % 4.5 %
Y / Y Operating Income Growth (Q2 TTM) 10.85 % 10.91 % 37.03 % 14.37 %
Sequential Operating Income Growth (Q2 TTM) 4.93 % -3.41 % 9.74 % 6.96 %
Operating Income 5 Year Avg. Change 7.6 % 11.5 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) 41.26 % 51938.12 % - 21.83 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) 17.47 % -18.73 % - 11.13 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) 12.37 % 22.13 % -25.13 % 16.46 %
Sequential Income from Cont. Ops. Change (Q2 TTM) 8.93 % 24.91 % -6.43 % 6.05 %
Income from Cont. Ops. 5 Year Avg. Change 5.91 % 5.35 % 0.17 % -28.52 %

MDT Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) 41.26 % - 16.75 % 21.56 %
Q / Q Net Income Growth (Q2 MRQ) 17.47 % -34.95 % -34.6 % 11.12 %
Y / Y Net Income Change (Q2 TTM) 12.37 % 5.68 % 32.74 % 16.59 %
Sequential Net Income Change (Q2 TTM) 8.93 % 26.32 % 7.31 % 6.03 %
Net Income 5 Year Avg. Growth 5.91 % 4.12 % 9.21 % 22.96 %

MDT's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) 41.98 % 49750.99 % - 21.83 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) - -17.51 % - 11.13 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) -90.91 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) - - - -99.7 %
EPS from Cont. Ops. 5 Year Avg. Growth 6.95 % -1.8 % 0.17 % -28.52 %



MDT EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) 40.74 % - 16.75 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) - -33.97 % -34.6 % 11.12 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - -99.97 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) 3300 % - - -99.87 %
EPS Net 5 Year Avg. Change 7 % 4.12 % 9.21 % 22.96 %



Medtronic Plc showed respectable 40.74% year on year rise of EPS in the first quarter, comparing favorably to the 7.07% growth in the Medical Equipment & Supplies industry, and 16.75% improvement in the Healthcare sector. Despite modest earnings per share rises in the Healthcare sector and Medical Equipment & Supplies industry, Medtronic Plc reported above average market earnings per share growth.

the bottom-line fell by -0.53% from the fourth quarter. Average annual income per share growth for Medtronic Plc is 7%, while S & P 500's average yearly income per share increase is 22.96%, including only Businesses with the first quarter 2026 earnings.

MDT Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) 120.89 % 9.68 % -10.43 % 2 %
Sequential Free Cash Flow Change (Q2 MRQ) -38.13 % 11.07 % -28.82 % 22.32 %
Y / Y Free Cash Flow Change (Q2 TTM) 15.63 % 11.94 % 11.09 % 11.81 %
Sequential Free Cash Flow Change (Q2 TTM) 13.01 % 3.69 % 1.93 % 2.41 %
Free Cash Flow 5 Year Avg. Change 2.12 % 3.81 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - -90.24 % 1035.72 %
Sequential Net Cash Flow Change (Q2 MRQ) - -90.75 % -99.01 % -
Y / Y Net Cash Flow Change (Q2 TTM) - 30.83 % -23.28 % -
Sequential Net Cash Flow Change (Q2 TTM) - 1641.65 % -25.11 % -
Net Cash Flow 5 Year Avg. Change - -9.69 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) -0.2 % 4.78 % 9.45 % 23.41 %
Sequential Capital Expenditures Change (Q2 MRQ) 3.07 % 10.56 % 18.78 % 18.97 %
Y / Y Capital Expenditures Change (Q2 TTM) 3.26 % -1.74 % 10.57 % 23.88 %
Sequential Capital Expenditures Change (Q2 TTM) -0.05 % 2.72 % 6.56 % 7.02 %
Capital Expenditures 5 Year Avg. Change 7.04 % 8.3 % 9.18 % 14.72 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.